BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 12075703)

  • 1. Combined modality therapy for non-small cell lung carcinoma.
    Machtay M; Glatstein E
    Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
    Hoffmann H
    Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.
    Bunn PA
    Clin Lung Cancer; 2004 Sep; 6(2):85-98. PubMed ID: 15476594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
    Johnson BE; Rabin MS
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
    Barlési F
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of a unique population in non-small cell lung cancer: systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy.
    Socinski MA; Stinchcombe TE; Hayes DN; Morris DE
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S32-8. PubMed ID: 16472707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality therapy for stage III non-small-cell lung cancer.
    Farray D; Mirkovic N; Albain KS
    J Clin Oncol; 2005 May; 23(14):3257-69. PubMed ID: 15886313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
    Girard N; Mornex F
    Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which treatments should be proposed in resectable stage III cancers?].
    Thibout Y; Cortot A; Chapet O; Mornex F; Milleron B
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S37-42. PubMed ID: 15536351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined-modality therapy for lung cancer].
    Miura S; Yamamoto N
    Nihon Rinsho; 2010 Jun; 68(6):1121-8. PubMed ID: 20535966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined modality therapy for stage III non-small-cell lung cancer.
    Anderson CS; Curran WJ
    Semin Radiat Oncol; 2010 Jul; 20(3):186-91. PubMed ID: 20685581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
    Patel V; Shrager JB
    Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
    Wakelee H; Dubey S; Gandara D
    Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction therapy before surgery for non-small cell lung cancer.
    Ferraldeschi R; D'Auria G; Ceratti Ade P; Assalone P; Mentuccia L; Ciprotti M; Evangelista ML; Mazzoli M; Di Fonzo C; Cortesi E
    Rays; 2004; 29(4):445-52. PubMed ID: 15852734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
    van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
    J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy for stage IIIa non-small cell lung cancer].
    Zhao LQ; Hou SC; Li H; Hu B; Wang Y
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2030-2. PubMed ID: 16313794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.